Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5603_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Aim and Scope
- •Preface
- •Acknowledgments
- •Contents
- •Contributors
- •About the Editors
- •1.1 Introduction
- •1.2.1 Friction
- •1.2.1.3 Friction Under Lubricated Conditions
- •1.7.1 Joint Tribology
- •1.7.2 Skin Tribology
- •1.7.3 Oral Tribology
- •1.8 Summary
- •References
- •2.1 Introduction
- •2.3.1 Fluid Pressurization/Fluid-Film Lubrication
- •2.3.2 Boundary Lubrication
- •2.3.3 Hydrodynamic Lubrication
- •2.3.4 Squeeze-Film Lubrication
- •2.3.5 Synovial Fluid
- •2.3.6 Hydration Lubrication
- •2.5.2 Scaffolds
- •2.5.3 Synthetic Polymer
- •2.5.4 Polyacrylamide
- •2.5.5 PEG Hydrogel
- •2.5.6 PVA Hydrogel
- •2.5.7 Double Network Hydrogel
- •2.5.8 Triple Network Hydrogel
- •2.6.1 Polyacrylamide
- •2.6.2 PEG Hydrogel
- •2.6.3 PVA Hydrogel
- •2.6.4 Double Network Hydrogel
- •2.6.5 Triple Network Hydrogel
- •2.7.1 Mechanical Properties
- •2.7.2 Structural Properties
- •2.8 Conclusion
- •References
- •3.1 Introduction
- •3.3.1 Label-Based Biosensors
- •3.3.2 Label-Free Biosensors
- •3.4 Different Nanobiosensing Techniques
- •3.4.1 Optical Sensing
- •3.4.2 Electrochemical/Electrical Sensing
- •3.4.3 Magnetic Sensing
- •3.4.4 Mass-Based Sensing
- •3.6.2 Neurodegenerative Diseases
- •3.6.3 Infectious Diseases
- •3.6.4 Metabolic Diseases
- •References
- •4.1 Introduction
- •4.2.1 Surface Functionalization
- •4.2.2 Bioconjugation
- •4.3 Synthesis Approach
- •4.3.1 Hydrothermal Method
- •4.3.2 Chemical Vapor Deposition (CVD)
- •4.3.3 Wet Chemical Method
- •4.4 Plasmonic Black Bodies (PBBs)
- •4.4.1 Gold NP (AuNPs)-Based PBB
- •4.4.2 Silver NPs (Ag NPs)-Based PBB
- •4.4.3 Platinum NPs (Pt NPs)-Based PBB
- •4.5 Biomimetic NP
- •4.6 Upconverting NP (UCNP)
- •4.6.1 Synthesis
- •4.7 Inorganic NP
- •4.7.1 Synthesis
- •4.8 Photothermal Therapy (PTT)
- •4.9 Conclusion
- •References
- •5.1 Introduction
- •5.2 Human Skin
- •5.10 Future Scope
- •5.11 Conclusion
- •References
- •6.1 Introduction
- •6.1.1 Class 1
- •6.1.2 Class 2
- •6.1.3 Class 3
- •6.4.1.1 Surface Patterning
- •6.4.1.2 Direct-Write Patterning
- •6.4.1.5 Dip-Pen Nanotechnology
- •6.4.1.7 Composing Using Beams
- •6.4.1.8 Direct Write Photolithography (DWP)
- •6.4.1.9 Light-Beam Lithography Electron
- •6.4.1.10 Focused Ion Beam Lithography
- •6.4.2 Fabrication Techniques
- •6.4.2.4 Non-invasive Glucose Monitoring Devices Technique
- •6.4.2.6 Cost-Effective Electrochemical Voltametric Sensors Techniques
- •6.4.2.7 Three-Dimensional (3D) Printing Techniques
- •6.4.2.8 UV-LED Stereolithography Printer Technique
- •6.4.2.9 4D Printing Techniques
- •6.4.2.10 Advanced Biomedical Techniques Involving Biorobots
- •References
- •7.1 Introduction
- •7.6 Mechanical Biocompatibility Challenges
- •7.7 Poor Bio-Printing Resolution
- •7.9 Limited Biomaterial Selection
- •7.11 Conclusion
- •8.2 Animal Tribology
- •8.2.1 Joint
- •8.2.3 Integumentary Change
- •References
- •8.1 Introduction
- •8.3.1 Nanotribology
- •8.4 Green Tribology
- •8.5 Conclusion
- •References
- •9.1 Introduction
- •9.2 Bio-Tribological Issues
- •9.3.2 Bone Fracture Fixation
- •9.3.4 Cardiovascular Devices
- •9.3.5 Minimal Invasive Surgical Devices
- •References
- •10.1 Introduction
- •10.2.2.1 Structural Integrity
- •10.2.2.2 Controlled Release Properties
- •10.2.2.3 Enhanced Drug Loading Capacity
- •10.2.2.4 Tailored Material Properties
- •10.2.3.1 Biocompatibility
- •10.2.3.3 Mechanical Properties
- •10.2.3.4 Drug Compatibility
- •10.2.3.5 Fabrication Compatibility
- •10.3.1 Matrix Material Properties
- •10.3.4 Biocompatibility Assessment
- •10.3.4.1 In Vitro Cell Culture Studies
- •10.3.4.2 Hemocompatibility Studies
- •10.3.4.3 In Vivo Animal Studies
- •10.3.4.4 Histological Analysis
- •10.3.4.5 Immune Response Evaluation
- •10.3.4.6 Biodegradation Assessment
- •10.4 Surface Engineering Considerations
- •10.4.2.1 Surface Coatings
- •10.4.2.2 Plasma Treatment
- •10.4.2.3 Surface Grafting
- •10.4.2.4 Dip Coating
- •10.4.2.5 Spray Coating System
- •10.4.2.6 Electrotreated Coating
- •10.4.2.9 Microfabrication Techniques
- •10.4.2.10 Surface Roughness Control
- •10.5.1.2 Mechanical Properties
- •10.5.1.3 Surface Characteristics
- •10.5.1.4 Release Kinetics Analysis
- •10.5.1.5 Biological Compatibility
- •10.5.1.7 Other Analyses
- •10.6 Advanced Fabrication Techniques
- •10.8 Conclusion
- •References
- •11.1 Introduction
- •11.2 Shape Memory Alloys (SMA)
- •11.3 Shape Memory Polymers
- •11.3.1 Heat
- •11.3.2 Light
- •11.3.3 Magnetic Field
- •11.4 Shape-Changing Hydrogels
- •11.5 Biomedical Applications
- •11.6 Conclusion
- •References
- •12.1 Introduction
- •12.3 Bioresorbable Orthopedic Implants
- •12.4.1 Polylactides
- •12.4.2 Poly (Ortho Esters)
- •12.4.3 Polyphosphoesters
- •12.4.4 Polyphosphazenes
- •12.4.5 Polycaprolactone
- •12.4.6 Polyurethanes
- •12.4.7 Polycarbonates
- •12.5.1 Compression Molding
- •12.5.2 Transfer Molding
- •12.5.3 Injection Molding
- •12.5.4 Extrusion
- •12.5.5 Blow Molding
- •12.5.6 Calendering Process
- •12.5.7 Fiber Spinning
- •12.5.8 Thermoforming
- •12.5.9 Polymer Foaming
- •12.7 Challenges
- •12.8 Conclusion
- •References
- •13.1 Introduction
- •13.3.1.1 Total Hip Replacement (THR)
- •13.3.2 Resurfacing Hip Replacement (RHR)
- •13.5.1 Adhesive Wear
- •13.5.2 Abrasive Wear
- •13.5.3 Fatigue Wear
- •13.5.4 Corrosion/Oxidative Wear
- •13.5.5 Surface Cracking
- •13.6.1 Metallic Implants
- •13.6.1.1 Stainless Steel
- •13.6.1.2 Co-Cr Alloys
- •13.6.1.3 Ti-Alloy
- •13.6.2 Ceramic Implants
- •13.6.3 Polymer Implants
- •13.6.4 Composite Implants
- •13.6.5.2 Surface Coatings
- •13.7.2.1 Hydrodynamic Lubrication
- •13.7.2.2 Boundary Lubrication
- •13.7.2.3 Elastohydrodynamic Lubrication
- •13.7.3 Biomimetic Lubrication Approaches
- •13.7.3.1 Replicating Natural Lubrication Mechanisms
- •13.7.4.1 Implant Wear
- •13.7.4.3 Synovial Fluid Degradation
- •13.8.1 Hydroxyapatite Coatings
- •13.8.1.1 Bone Integration
- •13.8.1.2 Implant Stability
- •13.8.1.4 Biocompatibility
- •13.8.2 Diamond-Like Carbon Coatings
- •13.8.3 Metal Nitride Coatings
- •13.8.4 Polymeric Coatings
- •13.8.5 Nanocomposite Coatings
- •13.9.1 Pin-on-Disk Testing
- •13.9.2 Hip Joint Simulators
- •13.9.3 Knee Joint Simulators
- •13.9.4 Tribo-Corrosion Testing
- •13.9.5 Wear Debris Analysis Techniques
- •13.9.5.1 Scanning Electron Microscopy (SEM)
- •13.9.5.2 Energy-Dispersive X-Ray Spectroscopy (EDS)
- •13.10.1.1 Tailored Geometries
- •13.10.1.2 Improved Wear Characteristics
- •13.10.1.3 Accelerated Innovation
- •13.10.2.1 Real-Time Wear Monitoring
- •13.10.2.2 Functionality Assessment
- •13.10.2.3 Implant Status Monitoring
- •13.10.2.4 Patient-Centric Healthcare
- •13.10.3.1 Advanced Biomaterials
- •13.10.3.4 Multidisciplinary Approaches
- •13.10.4.1 Wear Data Analysis
- •13.10.4.2 Predictive Wear Patterns
- •13.10.4.3 Early Intervention Strategies
- •13.10.4.4 Personalized Treatment Plans
- •13.11 Conclusion
- •References
- •14.1 Introduction
- •14.2.1 Powder Bed Fusion (PBF)
- •14.2.2 Directed Energy Deposition
- •14.3.1 Extrusion-Based AM
- •14.5 Biomanufacturing
- •14.5.1 Tissue Engineering
- •14.5.2 Organ-on-a-Chip Models
- •14.6 Conclusion
- •References
- •Index

Chapter 4
Biological Smart Materials: Materials
forCancer Treatment
DebasishPanda, MansiAgarwal, BeautyKumari, PrabhuduttaHota,
andAjayAgarwal
Abstract The eld of biomedical materials has witnessed signicant advance-
ments in recent years, leading to the development of novel smart materials capable
of interacting intelligently with the biological environment. This book chapter comprehensively explores the synthesis, applications, and safety considerations of
nanomaterials in the context of cancer treatment. The chapter begins with an introduction to nanotechnology and its signicance in biomedical research and cancer
therapeutics. Next, the chapter explores the synthesis of nanomaterials, covering
both top-down and bottom-up approaches. The top-down approach involves the fabrication of nanoparticles (NPs) from more extensive materials through techniques
such as milling and lithography. In contrast, the bottom-up approach focuses on
assembling nanoscale building blocks to form NPs using chemical synthesis and
self-assembly methods. It highlights the importance of material selection, processing techniques, and integrating functional components, such as NPs, nanobers, and
hydrogels, to enhance their performance and efcacy. Furthermore, the chapter discusses bioconjugation strategies for biomedical applications, emphasizing their role
in improving NP functionality and targeting abilities for cancer treatment. Various
D. Panda
RIMS Group, Indian Institute of Technology (I.I.T.), Jodhpur, India
Department of Electrical Engineering, Indian Institute of Technology (I.I.T.), Jodhpur, India
Department of Biomedical Engineering, All Indian Institute of Medical Science (AIIMS),
Jodhpur, India
M. Agarwal · B. Kumari
Department of Bioscience and Bioengineering, Indian Institute of Technology (I.I.T),
Jodhpur, India
P. Hota
Department of Biotechnology, National Institute of Technology (N.I.T), Rourkela, India
A. Agarwal (*)
RIMS Group, Indian Institute of Technology (I.I.T.), Jodhpur, India
Department of Electrical Engineering, Indian Institute of Technology (I.I.T.), Jodhpur, India
e-mail: ajayagarwal@iitj.ac.in
A. Kumar etal. (eds.), Applications of Biotribology in Biomedical Systems,
https://doi.org/10.1007/978-3-031-58327-8_4
113© The Author(s), under exclusive license to Springer Nature Switzerland AG 2024

114
D. Panda etal.
techniques, including surface modication and functionalization, are discussed to
enhance the biocompatibility and specicity of NPs in targeting cancer cells. The
chapter further delves into specic types of NPs used in cancer treatment. Plasmonic
NPs, known for their unique optical properties, are examined for their applications
in cancer therapy. Their use in photothermal therapy (PTT) is discussed, highlighting their potential in targeted cancer cell destruction. Inorganic-based NPs, specically those employed in drug delivery systems and PTT, are investigated for their
effectiveness in cancer treatment. Their controlled drug release mechanisms and
targeted therapy capabilities are explored, showcasing their potential in combating
cancer cells. Upconverting NPs, which can convert low-energy photons into highenergy emissions, are discussed in the context of cancer treatment. Their applications in PTT are explored, highlighting their potential for precise cancer cell
targeting and destruction. Inspired by nature’s mechanisms, biomimetic-based
materials for cancer treatment are examined. These materials mimic biological systems to enhance PTT, offering promising avenues for targeted cancer therapy.
Keywords Nanomaterials · Photothermal therapy · Photodynamic therapy ·
Targeted cancer therapy
4.1 Introduction
In the realm of modern science and healthcare, an awe-inspiring transformation is
taking place at the intersection of nanotechnology and biomedical research. At the
forefront of this revolution are biological smart materials, particularly nanomaterials, which are poised to redene the landscape of cancer therapeutics [1]. These
minute structures exhibit extraordinary properties that enable precise interactions at
the cellular and molecular levels, propelling them into the spotlight for innovative
approaches to combat diseases, especially cancer. These materials have the potential
to revolutionize medication delivery, diagnosis, and therapy by navigating the complex pathways of the human body, ushering in a new age of customized medicine
[2]. To avoid toxicity, lack of selectivity, and improve drug capacity and bioavailability, nanomaterials have been created for a broad range of cancer treatments that
target cancer cells, the tumor microenvironment (TME), and the immune system
[3]. Cancer, an enigmatic and fatal disease continues to be investigated by medical
research, necessitating innovative and precise therapy tactics to enhance patient outcomes [4]. In order to avoid toxicity, lack of selectivity, and improve drug capacity
as well as bioavailability, a variety of cancer medicines have been created using
nanomaterials that target cancer cells, TME, and immune system [5]. Top-down and
bottom-up synthesis methods are the two basic strategies for creating nanomaterials.
The top-down method reduces the structure’s size to a nanoscale level, whereas the
bottom-up approach builds a massive nanostructure from smaller atoms and molecules [6]. Understanding these synthesis methods is vital for unlocking the future
potential of nanomaterials for cancer therapy and tailoring their characteristics to

4 Biological Smart Materials: Materials forCancer Treatment
115
specic applications. Bioconjugate methods are created with at least one biologically derived molecule in order to provide targeted drug delivery, reduce off-target
effects, and improve therapeutic effectiveness [7]. These bioconjugates are cuttingedge treatment modalities with potential synergistic anticancer effects, and they
have the strength to outperform the drawbacks of chemotherapeutics. To get around
these problems, researchers have combined different molecules, transport mechanisms, and imaging modalities with therapeutic agents or medications [8].
Plasmonic NPs and their assemblies have been widely used in biosensing, optical imaging, and biomedicine over the last few decades, and are one of the most
stimulating applications of nanomaterials in cancer therapy by selectively targeting
cancer cells through heat or light-induced effects [9]. The physicochemical features
of high-Z plasmonic NPs provide them with the ability to sensitize radiotherapy.
Plasmonic NPs allow light to be coupled to nanoscale objects through the collective
motion of conduction of plasmons in metals [10]. Due to their capacity to increase
therapeutic effectiveness by focusing on ligands while minimizing off-target adverse
effects via drug adsorption and penetration, inorganic-based NPs like metal oxides
and quantum dots offer various potential benets for drug delivery in the treatment
of cancer [11]. These NPs have developed the ability for integrated therapeutic
capabilities, such as anticancer effects through cytotoxicity, repression of oncogenes, and blockage of cancer cell signaling pathways [12]. For a variety of biological applications, including illness detection, medication administration, bioimaging,
and cancer treatment, organic-based NPs with specic characteristics have drawn
considerable interest [13]. Particularly, organic NPs have shown excellent promise
in drug delivery, bioimaging, and phototherapy. These NPs have distinguishing
qualities including tailorable synthesis, fast processing, optimal biocompatibility,
and minimal cytotoxicity [14]. Biomolecules such as nucleic acids, peptides, or
proteins have also been extensively exploited in the construction of useful nanostructures with a variety of topologies and dimensions, including medicines, uorescent dyes, and π-conjugated semiconducting polymers [15]. Furthermore,
upconverting NPs (UCNPs), with their potential to convert near-infrared light to
higher energy emissions, are efcient approaches in deep tissue imaging and therapy. In response to near-infrared (NIR) light stimulation, UCNPs are capable of
generating high-energy visible light that activates nearby photosensitizer (PS) molecules to produce singlet oxygen and destroy cancer cells [16]. The advancement of
nanotechnology allows for the integration of different types of biomaterials onto the
surface of NPs. Drawing inspiration from nature, biomimetic-based materials provide highly targeted and effective treatment options through drug delivery, photodynamic theory (PDT), and photothermal theory (PPT) approaches [17]. This mimicry
strategy promotes the escape of biomimetic NPs from immune system clearance
and decreases the possibility of potential toxic side effects [18]. As we expand further in the eld of nanomaterials for cancer therapy, it is essential to address potential concerns, such as toxicity and immunogenicity [19]. Particle size, shape, surface
area, and surface chemistry of NPs determine their toxicity, which is caused by their
predominate accumulation in organs with strong phagocytic activity, primarily in
the liver, kidney, and spleen. NPs may be delivered through inhalation, ingestion, or

116
skin penetration [20]. At the respiratory, cardiac, reproductive, renal, cutaneous, and
cellular levels, toxic effects have been seen that might be hazardous to the environment, animals, and human health, Therefore, the assessment of the safety proles of
these novel materials is crucial for their effective translation into clinical applications, assuring patient safety and optimal therapeutic outcomes [21]. From nanoscale
material manipulation to strategic bioconjugation methods, these novel methodologies hold the possibility of changing precision medicine. A harmonious convergence of scientic innovation and therapeutic potential is orchestrated by the
symphony of plasmonic NPs, inorganic and organic-based NPs, and biomimetic
materials. With each new discovery, we get closer to a future in which nanomaterials, pushed by interdisciplinary collaboration, catapult us beyond the boundaries of
conventional medical treatments. The use of nanomaterials for delivering immune
preparations results in a more powerful and long-lasting immune response than a
single immune preparation [22].
D. Panda etal.
4.2 Surface Modication toIncrease theBiocompatibility
Surface modication of 2D materials is a promising approach to enhance their biocompatibility for theranostic applications. By modifying the surface properties,
such as charge, hydrophobicity, and functional groups, it is possible to improve the
interaction between 2D materials and biological systems, minimize cytotoxicity,
and enable their use in various biomedical applications [23]. Here are some common surface modication strategies for increasing biocompatibility.
4.2.1 Surface Functionalization
Surface functionalization modies the surface characteristics of 2D materials by
adding functional groups or molecules to their surface [24]. To do this, a number of
chemical processes may be utilized, including silanization, thiolation, and diazonium chemistry. In the case of silanization, for instance, a silane compound reacts
with the material’s surface to create covalent connections between the molecules of
the silane and the atoms on the surface [25]. The addition of biocompatible polymers, such as polyethylene glycol (PEG), can create a hydrophilic and stealth-like
surface, reducing protein adsorption and immune response. This introduces new
functional groups and changes the surface properties of the 2D material. Functional
groups like amino (-NH2) or carboxyl (-COOH) can be introduced, which can serve
as reactive sites for further bioconjugation or facilitate interactions with biological
molecules [26]. These functional groups can also impart hydrophilicity or hydrophobicity to the surface, depending on the specic modication. By controlling the type

4 Biological Smart Materials: Materials forCancer Treatment
and density of the functional groups, the surface properties can be precisely tailored
to enhance biocompatibility and enable specic interactions with biological systems.
117
4.2.2 Bioconjugation
The process of bioconjugation involves the covalent bonding of bioactive molecules, such as antibodies or aptamers, to the surface of 2D materials [27]. This
strategy enables specic targeting and recognition of cells or biomolecules, enhancing biocompatibility and enabling targeted theranostic applications. Bioconjugation
can be achieved through various methods, including surface functionalization with
reactive groups or linker molecules. The bioactive molecules can be covalently
attached to the modied surface, providing specic binding sites for targeted interactions [28]. Examples include conjugating antibodies to the surface of 2D materials to enable targeted binding to cancer cells or disease indicators. This focused
binding may improve the effectiveness and reduce side effects of selective diagnostics or the administration of therapeutic medicines to certain cells or tissues [29].
4.3 Synthesis Approach
The fabrication techniques for 2D materials encompass processes utilized to create
materials featuring two-dimensional structures, like graphene, transition metal
dichalcogenides (TMDs), and layered substances. These methods are pivotal in
yielding top-tier 2D materials with regulated attributes and architectures [30].
Numerous synthesis strategies have been formulated, encompassing the hydrothermal approach, Chemical Vapor Deposition, and Wet Chemical Method. Let’s delve
into these methods in greater detail.
4.3.1 Hydrothermal Method
The hydrothermal method stands as a prominently employed synthesis technique in
crafting 2D materials. This process entails the reaction of precursor solutions or
suspensions within an aqueous environment characterized by high pressure and
temperature [31]. The reaction occurs within an autoclave or reaction vessel engineered to endure the requisite high-pressure conditions. Undoubtedly versatile and
extensively utilized, the hydrothermal method facilitates the creation of top-tier
materials endowed with controlled attributes [32]. This renders it well-suited for
diverse applications spanning electronics, energy storage, catalysis, and the biomedical realm.

118
D. Panda etal.
4.3.2 Chemical Vapor Deposition (CVD)
CVD is a widely used method for the synthesis and growth of thin lms and 2D
materials. It involves the building up of a thin lm material onto a substrate by introducing reactive gases into a reaction chamber. Within this chamber, the gases
undergo reactions, resulting in the deposition of the desired material onto the substrate’s surface [33]. In the CVD process, precursor gases containing the targeted
elements are introduced into the reaction chamber, typically maintained at elevated
temperatures. These precursor gases can be in the form of vapors, liquids, or solids
that vaporize during the process. Inside the chamber, the precursor gases undergo
chemical reactions, leading to the formation of volatile by-products and the deposition of the desired material onto the substrate [34].
4.3.3 Wet Chemical Method
It is also known as wet synthesis or solution-based synthesis, which involves the
chemical reaction of precursors in a liquid solvent to form the desired material. It is
a versatile and widely used method for the synthesis of various nanomaterials. In
this method, the precursors are dissolved in a solvent to form a reaction mixture. The
choice of solvent depends on the nature of the precursors and the desired properties
of the nal product. The reaction mixture then encounters specic conditions—such
as temperature, pH, and stirring—to initiate and regulate the chemical processes
[35]. The chemical reactions in the wet chemical method can include precipitation,
hydrothermal reactions, sol-gel processes, or reduction reactions, among others.
These reactions result in the formation of nanocrystals, NPs, or other nanomaterials.
Wet chemical synthesis has benets over dry chemical synthesis, including ease of
synthesis, scalability, and control over the size, shape, and content of the produced
materials. It makes it possible to create a variety of nanomaterials, such as metal
nanoparticles (NPs), quantum dots, metal oxides, and nanocomposites [36].
4.4 Plasmonic Black Bodies (PBBs)
The realm of modern healthcare is witnessing a transformative innovation known as
PBBs, a remarkable class of materials and structures characterized by their unique
ability to exhibit enhanced absorption and emission of light due to plasmonic
effects. As a pioneering eld within nanophotonics, PBBs have emerged as a promising frontier in addressing crucial challenges in cancer treatment, drug delivery,
imaging, and beyond [37]. Harnessing the intriguing behaviors of surface plasmons,
PBBs hold the potential to revolutionize the landscape of precision medicine by
offering tailored and efcient solutions to longstanding limitations in existing

4 Biological Smart Materials: Materials forCancer Treatment
119
therapies [38]. This not only uncovers the multi-faceted importance of PBBs in
today’s biomedical research but also unveils the varied spectrum of PBB types.
Within this array, standout examples include gold NPs [39] acclaimed for their
robust plasmonic behavior, making them indispensable in drug delivery and theranostics. Silver NPs, sharing similar plasmonic properties, nd application in drug
delivery and antibacterial contexts [40]. Gold or silver core-shell NPs are examples
of core- shell structures, couple metallic cores with protective dielectric shells,
ensuring enhanced stability, biocompatibility, and controlled therapeutic release.
Equally compelling, hybrid structures like mesoporous silica-coated PBBs harness
the power of gold or silver NPs encased within a mesoporous silica layer, enabling
efcient drug loading, controlled release, and plasmonic characteristics suitable for
therapy and imaging [41]. Polymer-encapsulated PBBs, exemplied by polymercoated gold nanorods, amalgamate plasmonic behavior with biocompatible polymers, ensuring stability, prolonged circulation, and controlled release [42]. Similarly,
plasmonic nanostructures like plasmonic nanoshells, with hollow structures composed of dielectric cores and metallic shells, and plasmonic nanocages, exhibiting
porous walls and large surface areas, stand as remarkable entities with potential in
targeted drug delivery and imaging [43]. This diverse spectrum of PBBs holds profound implications for elevating precision medicine through rened treatment
approaches and augmented therapeutic outcomes. This introductory glimpse not
only highlights the remarkable potential of PBBs in reshaping the landscape of
modern healthcare but also paves the way for a profound journey into their intricacies and vast potential. As we delve further, we will uncover how these unique
materials stand at the intersection of innovation and biomedical research, poised to
propel us beyond the boundaries of conventional therapies and into a new era of
precision medicine.
4.4.1 Gold NP (AuNPs)-Based PBB
In the dynamic landscape of modern biomedical exploration, the integration of
AuNPs has surfaced as an avenue of remarkable promise and transformative potential. These NPs, renowned for their extraordinary plasmonic attributes, especially
within the visible and near-infrared realms, are poised to reshape the landscape of
drug delivery and theranostics. Utilizing these characteristics, localized surface
plasmon resonance (LSPR) enables Au NPs to effectively absorb and scatter light
across a wide range of wavelengths. They are adaptable for a variety of biological
applications, including drug administration and theranostics, because of their tunability, which permits modication of their absorption and scattering characteristics
[44]. In drug delivery, Au NPs serve as carriers for therapeutic agents, providing
several benets. Their small size allows for easy penetration into tissues, while their
large surface area enables high drug-loading capacities [45]. Additionally, the surface of Au NPs may be functionalized with targeting ligands like antibodies or
peptides to make it easier for target cells or biomarkers to be recognized and bound.

120
D. Panda etal.
By enhancing the accumulation of therapeutic chemicals in the intended areas, this
tailored administration improves treatment effectiveness while reducing adverse
effects on healthy tissues [46]. Au NPs also play a crucial role in theranostics by
combining therapeutic and diagnostic functions. Their unique plasmonic properties
enable enhanced imaging capabilities. In techniques like dark-eld microscopy and
photoacoustic imaging, Au NPs act as contrast agents, enhancing contrast and resolution for precise imaging. This imaging aspect allows for real-time monitoring of
drug delivery, assessment of treatment response, and visualization of therapeutic
efcacy. Furthermore, Au NPs can be utilized in hyperthermia-based therapies [47].
By harnessing the plasmonic properties of Au NPs, localized heating can be
achieved when exposed to light, such as NIR laser irradiation. This localized hyperthermia effect selectively damages cancer cells while sparing healthy tissues, offering a promising approach for targeted cancer treatment. The combination of targeted
drug delivery and hyperthermia-based therapies using Au NPs holds great potential
in improving treatment outcomes and minimizing adverse effects [48]. Moreover,
the stability and biocompatibility of Au NPs, along with their tunability through
size and surface modications, make them well-suited for biomedical applications.
As we delve into their distinctive capabilities, AuNPs unveil a pathway toward precision medicine, presenting a sophisticated framework for rened therapeutic strategies and amplied diagnostic methodologies. These NPs can be engineered to
have optimal properties for drug delivery, such as controlled release proles and
long circulation times in the body [49]. Researchers, such as Choi etal. and Li etal.,
have explored the synthesis of Au-based nanostructures like Au@PDA nano worms
and GNR@PDA.Choi etal. [50] employed dopamine to synthesize gold nanoworms (AuNWs) encapsulated within a polydopamine (PDA) shell. The process
involved the rapid assembly of citrate-capped gold NPs into nanoworm structures
within a minute. Subsequently, dopamine initiated self-polymerization over 60min,
facilitating the growth of a conformal PDA shell on the outer surface of the AuNWs.
This PDA shell signicantly enhances the stability of the internal gold nanoworm
structure, resulting in core-shell Au@PDA nanoworms, with each worm possessing
around 4–5 gold cores. This synthesis approach not only ensured stability but also
precise control over the structure of the resulting Au@PDA nanoworms, rendering
them amenable to a range of applications. In another study by Li etal. [51], they
concentrated on creating GNR@PDA NPs, in which gold nanorods (GNRs) were
created via a seed-mediated technique and then covered with a shell made of polydopamine. Figure4.1a shows the form and size of as-prepared GNRs as determined
by TEM.High-quality GNRs had an aspect ratio of 3.6 (average width: 22nm;
average length: 81nm). The procedure for generating PEGylated gold nanorods
(GNRs) encompassed mixing GNRs with mPEG−SH followed by their collection
through centrifugation. The PEGylated GNRs were subsequently suspended in a
Tris buffer and subjected to sonication prior to the addition of dopamine. Dopamineis
self- polymerized and coated onto the surface of the PEGylated GNRs. The resulting
GNR@PDA NPs were collected through centrifugation. Figure4.1b, c represents
the TEM images of GNR@PDA NPs. The polydopamine shell contributed

4 Biological Smart Materials: Materials forCancer Treatment
Fig. 4.1 Synthesis of gold nanorods. (a) Aspect ratio of high-quality GNRs. (b, c) TEM images of
GNR@PDA NPs. (d) LSPR peak of CTAB-capped GNRs. (e) Absorption spectra of GNRs@PDA
PEGDOX.Photothermal stability test invivo. (f) Photothermal stability of GNRs. (g) Connection
between pH and laser irradiation. (h) Tumor ablation with laser irradiation. (i) Comparison of the
tumor weight with the control group. (j) PA imaging of the GNRs nanocarrier invivo grouping of
the xenograft-bearing mice. (l, m) Photothermal conversion efciencies of GNR nanocomposites
at two different concentrations. (Reprinted (adapted) with permission from American chemical
society [52])
121
additional functionalities and stability to the gold nanorods, enhancing their properties for various applications. Figure4.1d shows the LSPR peak of CTAB-capped
GNRs at 850 nm.
4.4.2 Silver NPs (Ag NPs)-Based PBB
Due to their LSPR effect, the Ag NPs have remarkable plasmonic properties that are
especially noticeable in the visible range. These Ag NPs have the capacity to efciently capture and manipulate light, rendering them a compelling candidate for
PBB applications. In the realm of drug delivery and theranostics, Ag NPs offer a
myriad of advantages [53]. Functioning as versatile carriers, their small size and
substantial surface-to-volume ratio enable efcient drug loading. Moreover, Ag
NPs’ plasmonic attributes can be harnessed to achieve controlled drug release at
specic sites via external stimuli like light or temperature [54]. Under light irradiation, Ag PBBs generate localized heating, facilitating on-demand drug delivery.
Augmenting their potential, the incorporation of targeting ligands enhances binding
to cancer cells, ensuring precise drug delivery. Ag PBBs also excel in theranostics
by integrating therapeutic and diagnostic roles. Their plasmonic properties enhance

122
D. Panda etal.
imaging capabilities, making them indispensable contrast agents for optical imaging techniques. Capitalizing on Ag NPs’ scattering and absorption properties bolsters image resolution, allowing real-time observation of drug delivery and treatment
efcacy. To address oxidation concerns, surface functionalization and size, shape,
and aggregation control strategies are employed, safeguarding their stability. By
coating Ag NPs with biocompatible materials, their circulation longevity is
improved, fostering enhanced therapeutic outcomes. Altogether, the remarkable
plasmonic features of Ag NPs open new vistas for precise drug delivery and theranostic endeavors, holding the potential to transform biomedical applications [55].
Researchers, such as Mondal etal. and Bose etal., have employed various synthesis
methods to create tailored Ag NPs for specic applications. These include the creation of plasmonic silver triangular nanoprisms coated with polyvinyl alcohol for
enhanced physicochemical qualities and the manufacture of anisotropic silver NPs
with surface alterations for targeted drug administration. Mondal et al. [56]
employed a synthesis method to create plasmonic anisotropic silver NPs (AgNPs).
The process involved mixing AgNO3 and citrate solutions, the addition of hydrazine
hydrate immediately after that careful pH control was maintained throughout the
synthesis. Subsequently, folic acid was conjugated to the AgNPs, resulting in folate
receptor-targeted AgNPs (FA-AgNPs). Further modication involved quenching
quercetin (QRC) onto the surface of the FA-AgNPs, leading to the formation of
QRC-FA-AgNPs. In a study by Bose etal. [57], dynamic chemical synthesis of
polyvinyl alcohol-coated plasmonic silver triangular nanoprisms (PVA-SNT)was
accomplished. The synthesis process involved mixing a polyvinyl alcohol aqueous
solution with AgNO3 and sodium citrate, followed by the addition of H2O2 and
NaBH4. Color changes in the resulting solution indicated the successful formation
of PVA-coated silver triangular nanoprisms. A similar synthesis procedure was
employed to synthesize silver triangular NPs (SNT), replacing the PVA solution
with deionized water. The synthesized PVA-SNT and SNT NPs underwent characterization using various techniques.
4.4.3 Platinum NPs (Pt NPs)-Based PBB
Pt NPs also exhibit plasmonic behavior in the UV-visible range, which presents
potential value in drug delivery and theranostics applications. Although Pt NPs are
less commonly explored in this context compared to other metals like gold (Au) and
silver (Ag), they offer unique advantages. In the eld of drug delivery, Pt PBBs
serve as carriers for therapeutic agents. Their small size and large surface area-tovolume ratio enable efcient drug loading, allowing for precise control over drug
release [58]. Additionally, the plasmonic properties of Pt NPs can be utilized to
trigger drug release through light irradiation, providing a means for targeted and
controlled drug delivery. By utilizing external stimuli such as light, localized heating can be generated, facilitating the release of drugs specically at the desired sites.
Surface functionalization of Pt NPs with targeting ligands enhances their specicity
Соседние файлы в папке Библиотека им академика М.И. Перельмана
